Contact:

[PR Contact]

[Clinic]

[Phone]

[Email]

[CLINIC NAME] Introduces Non-Invasive Laser Therapy for Glaucoma: SLT

[City, Date] On (add date) the [CLINIC NAME] announced the introduction of SLT, an innovative, non-invasive laser treatment for glaucoma. This quick and simple procedure maybe an option for most patients, but is especially suited for patients who cannot tolerate or are unable to self-administer glaucoma medications.

Highly effective, SLT is used as primary treatment for early stages of open angle glaucoma, and can also be used in combination with drug therapy or as an alternative therapy when drugs fail. It is also a flexible treatment option, given that it can be repeated, if necessary, depending on the individual patient’s response.

Glaucoma is the leading cause of blindness in North America and Europe and the second leading cause worldwide. It is most often associated with an increase of pressure inside the eye, which, over time, can cause damage to some of the sensitive structures that receive and transmit images in the back of the eye, ultimately resulting in irreversible loss of vision.

SLT uses the principle of photoregeneration: the SLT laser applies short pulses of low-energy light to prompt a photo-regenerative response in the trabecular meshwork of the eye, which leads to lowered intraocular pressure. Gentle, non-invasive and repeatable, SLT promotes cellular regeneration without the burn and tissue scarring associated with other conventional laser procedures for glaucoma.

Good candidates for SLT include primary-open angle, normal tension, pseudoexfoliation, or pigmentary glaucoma patients who:

  • Wish to use SLT as a primary glaucoma treatment
  • Find it challenging to take glaucoma medications due to time or financial constraints, non-compliance and quality-of-life issues
  • Are currently undergoing drug therapy and need to further reduce IOP without adding drugs
  • Wish to keep the number of drugs to a minimum
  • Do not tolerate drugs due to their adverse effects
  • Experience loss of the pressure-lowering effects of drug therapy
  • Have had Argon Laser Trabeculoplasty that has failed

“We are excited to be among the first clinics in (ADD COUNTRY) to offer this gentle, non-invasive treatment option to our patients” says Dr. [DOCTOR’S NAME],Medical Director at [CLINIC NAME]. Since its original introduction we have been following the clinical studies and outcomes related to SLT closely and we view it as a safe and effective treatment for open-angle glaucoma – including primary therapy, adjunct therapy with drugs, and alternative therapy when drugs fail. SLT isespecially suited to patients that have compliance issues or do not tolerate the medication“.

About [CLINIC NAME]

[ADD BOILER PLATE, 50 WORD SUMMARY ABOUT THE CLINIC]

-more-